Atara Biotherapeutics Ownership | Who Owns Atara Biotherapeutics?


OverviewForecastRevenueFinancialsChart

Atara Biotherapeutics Ownership Summary


Atara Biotherapeutics is owned by 2.79% institutional investors, 20.58% insiders, and 76.63% retail investors. Ecor1 capital is the largest institutional shareholder, holding 4.70% of ATRA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.05% of its assets in Atara Biotherapeutics shares.

ATRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtara Biotherapeutics2.79%20.58%76.63%
SectorHealthcare Stocks 232.51%10.72%-143.23%
IndustryBiotech Stocks 384.56%10.58%-295.14%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ecor1 capital573.18K4.70%$8.21M
Redmile group441.70K3.62%$6.33M
Vanguard group225.94K1.67%$4.09M
Marshall wace, llp115.80K0.95%$1.66M
Globeflex capital l p77.22K0.57%$1.40M
Mackenzie financial63.82K0.52%$914.48K
Blackrock funding, inc. /de67.11K0.49%$1.21M
Geode capital management62.38K0.46%$1.13M
Acadian asset management54.05K0.40%$976.00K
Staley capital advisers50.00K0.37%$904.50K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group441.70K0.62%$6.33M
Ecor1 capital573.18K0.39%$8.21M
Globeflex capital l p77.22K0.21%$1.40M
Staley capital advisers50.00K0.04%$904.50K
Bridgeway capital management14.00K0.00%$200.62K
Quadrature capital16.54K0.00%$236.88K
Private wealth asset management900.000.00%$16.28K
Marshall wace, llp115.80K0.00%$1.66M
Acadian asset management54.05K0.00%$976.00K
Cambridge investment research advisors22.86K0.00%$414.00K

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp115.80K0.00%73.44K
Globeflex capital l p77.22K0.21%61.77K
Mackenzie financial63.82K0.00%41.30K
Vanguard group225.94K0.00%22.50K
Quadrature capital16.54K0.00%16.54K

Top Sellers

HolderShares% AssetsChange
Blackrock---6.83M
Bank of america corp /de/---6.58M
Price t rowe associates inc /md/---4.96M
Aqr capital management---2.63M
Woodline partners lp---1.77M

New Positions

HolderShares% AssetsChangeValue
Quadrature capital16.54K0.00%16.54K$236.88K
Connor, clark & lunn investment management10.45K0.00%10.45K$188.97K
Dimensional fund advisors lp10.03K-10.03K$181.41K
Federated hermes130.00-130.00$2.35K
Rockefeller capital management8.00-8.00$115.00

Sold Out

HolderChange
Citigroup-2.00
Nelson, van denburg & campbell wealth management group-23.00
Eversource wealth advisors-35.00
Nisa investment advisors-50.00
Gamma investing-56.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20257-81.08%379,045-79.87%21.17%3-81.25%1-85.71%
Sep 30, 20258-73.33%233,049-86.80%10.91%3-62.50%--100.00%
Jun 30, 202532-8.57%1,803,95019.18%147.48%11-8.33%6-53.85%
Mar 31, 202536-14.29%2,086,297-10.96%194.03%13-43.48%1318.18%
Dec 31, 20242100.00%6380.00%-360000.00%1---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF120.26K2.05%-
Vanguard Total Stock Mkt Idx Inv117.69K1.69%-2.57K
Vanguard Institutional Extnd Mkt Idx Tr49.27K0.71%-17.18K
Fidelity Extended Market Index28.89K0.41%-238.00
Fidelity VIP Disciplined Small Cap Init16.24K0.23%-
Bridgeway Ultra-Small Company Market14.00K0.20%-
Fidelity Enhanced Small Cap ETF10.45K0.18%-
NT R2000 Value Index Fund - NL255.47K0.18%-
NT R2000 Index Fund - NL9.83K0.17%-1.01K
Fidelity Total Market Index10.57K0.15%-22.00

Recent Insider Transactions


DateNameRoleActivityValue
Jan 12, 2026Panacea Innovation Ltd-Sell$489.02K
Nov 17, 2025Nguyen AnhCo President and CEOSell$738.53
Nov 17, 2025Nguyen AnhCo President and CEOSell$37.70K
Nov 17, 2025Grant-Huerta Yanina Chief Accounting OfficerSell$1.12K
Nov 17, 2025Grant-Huerta Yanina Chief Accounting OfficerSell$21.69K

Insider Transactions Trends


DateBuySell
2025 Q4-5
2025 Q326
2025 Q2-2
2025 Q1-3
2024 Q4-3

ATRA Ownership FAQ


Who Owns Atara Biotherapeutics?

Atara Biotherapeutics shareholders are primarily institutional investors at 2.79%, followed by 20.58% insiders and 76.63% retail investors. The average institutional ownership in Atara Biotherapeutics's industry, Biotech Stocks , is 384.56%, which Atara Biotherapeutics falls below.

Who owns the most shares of Atara Biotherapeutics?

Atara Biotherapeutics’s largest shareholders are Ecor1 capital (573.18K shares, 4.70%), Redmile group (441.7K shares, 3.62%), and Vanguard group (225.94K shares, 1.67%). Together, they hold 9.99% of Atara Biotherapeutics’s total shares outstanding.

Does Blackrock own Atara Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Atara Biotherapeutics.

Who is Atara Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Redmile group is Atara Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.62% of its assets in 441.7K Atara Biotherapeutics shares, valued at 6.33M$.

Who is the top mutual fund holder of Atara Biotherapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Atara Biotherapeutics shares, with 2.05% of its total shares outstanding invested in 120.26K Atara Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools